{"transactions":[{"id":4627822,"issuer":{"id":6454,"kind":"organization","name":"Conexeu Sciences Inc.","symbol":"CNXU"},"owners":[{"id":48390,"kind":"person","name":"Bogart David Robert","position":1,"cik":"0002128417","reported_name":"Bogart David Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Performance Warrants","published_at":"2026-09-28T21:38:52.000Z","date":"2026-09-25","kind":"exercise","planned":false,"acquired":false,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction is also exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Act\") pursuant to Rule 16b-6(b) promulgated under the Act."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Performance Warrants were granted on June 5, 2025 and have an exercise price of $0.001 and a term of 5 years. The Performance Warrants were granted for services rendered to the issuer and no price was paid for the Performance Warrants. 750,000 Performance Warrants have vested. The remaining 250,000 Performance Warrants will vest and be exercisable upon the Issuer submitting a 510(k) application to the United States Food and Drug Administration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Performance Warrants were granted on June 5, 2025 and have an exercise price of $0.001 and a term of 5 years. The Performance Warrants were granted for services rendered to the issuer and no price was paid for the Performance Warrants. 750,000 Performance Warrants have vested. The remaining 250,000 Performance Warrants will vest and be exercisable upon the Issuer submitting a 510(k) application to the United States Food and Drug Administration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Performance Warrants were granted on June 5, 2025 and have an exercise price of $0.001 and a term of 5 years. The Performance Warrants were granted for services rendered to the issuer and no price was paid for the Performance Warrants. 750,000 Performance Warrants have vested. The remaining 250,000 Performance Warrants will vest and be exercisable upon the Issuer submitting a 510(k) application to the United States Food and Drug Administration."}],"balance_after":250000,"derivative":{"exercise_price":0.001,"expiration_date":"2030-06-05","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001062993-26-005090","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2128417/000106299326005090/form4.xml","form_type":"4"}},{"id":4627821,"issuer":{"id":6454,"kind":"organization","name":"Conexeu Sciences Inc.","symbol":"CNXU"},"owners":[{"id":48390,"kind":"person","name":"Bogart David Robert","position":1,"cik":"0002128417","reported_name":"Bogart David Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-09-28T21:38:52.000Z","date":"2026-09-25","kind":"exercise","planned":false,"acquired":true,"shares":750000,"price":0.001,"value":750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction is also exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Act\") pursuant to Rule 16b-6(b) promulgated under the Act."}],"balance_after":1812500,"source":{"system":"sec-edgar","filing":"0001062993-26-005090","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2128417/000106299326005090/form4.xml","form_type":"4"}}]}